AllerNaze FDA Approval History
FDA Approved: Yes (First approved January 7, 2009)
Brand name: AllerNaze
Generic name: triamcinolone acetonide
Dosage form: Nasal Spray
Previous Name: AllerNase
Company: Collegium Pharmaceutical, Inc.
Treatment for: Allergic Rhinitis
Marketing Status: Discontinued
AllerNaze, formerly Tri-Nasal (triamcinolone acetonide, USP) is a reformulated aqueous intranasal steroid nasal spray indicated for the once daily treatment of nasal symptoms associated with both seasonal and perennial allergic rhinitis in adults and children twelve years of age and older.
Development timeline for AllerNaze
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
